Effect of prenatal supplementation with vitamin D on asthma or recurrent wheezing in offspring by age 3 years – Pharmacy Today, American Pharmacists Association, pharmacist.com


JAMA: The Journal of the American Medical Association

Effect of prenatal supplementation with vitamin D on asthma or recurrent wheezing in offspring by age 3 years
Pharmacy Today, American Pharmacists Association, pharmacist.com
Lack of vitamin D during pregnancy can lead to breathing disorders early in a child's life. Researchers tested whether prenatal vitamin D supplementation could prevent asthma or recurrent wheezing by administering specific doses to 876 women aged …
Prenatal Vitamin D and Baby's Asthma RiskWebMD
Effect of Prenatal Supplementation With Vitamin D on Asthma or Recurrent Wheezing in Offspring by Age 3 Years: The JAMA: The Journal of the American Medical Association
Lower Asthma Risk From Prenatal Vitamin D Unconfirmed But Supplement Isn't a Bad Idea: ExpertsLatinos Health
EurekAlert (press release)
all 30 news articles »

View full post on asthma – Google News

New treatment for severe asthma – Pharmacy Today, American Pharmacists Association, pharmacist.com

New treatment for severe asthma
Pharmacy Today, American Pharmacists Association, pharmacist.com
In early November, FDA approved mepolizumab (Nucala—GlaxoSmithKline), a novel treatment for severe asthma. This new treatment is an interleukin-5 (IL-5) antagonist that works by inhibiting IL-5 signaling, with subsequent reduction in the production

View full post on asthma – Google News

Asthma Prevalence Rising Among Poorer, Older Children – MedPage Today


MedPage Today

Asthma Prevalence Rising Among Poorer, Older Children
MedPage Today
While overall asthma prevalence has declined, recent trends indicate increases in the condition among poor children and older children, a retrospective analysis of National Health Interview Survey data from 2001-2013 found. Using adjusted multivariate …
Kids' asthma rates quiet down after earlier increase: StudyBristol Herald Courier (press release) (blog)
Overall Increase in Childhood Asthma Ceased, but Not for PoorMonthly Prescribing Reference (registration)

all 15 news articles »

View full post on asthma – Google News

Asthma linked to increased risk of shingles – Medical News Today


Medical News Today

Asthma linked to increased risk of shingles
Medical News Today
Of the 371 shingles patients, 87 (23%) had asthma, compared with 114 of the 742 (15%) controls. Using a statistical method called logistic regression, the researchers calculated that adults with asthma appeared to have a 70% higher risk of developing …
Childhood Asthma May Be 'Unrecognized Risk Factor' For Shingles Later On In LifeMedical Daily
Childhood asthma may increase risks of shinglesEurekAlert (press release)
Shingles Risk Higher In Patients Who Had Childhood AsthmaScience World Report

all 28 news articles »

View full post on asthma – Google News

Independent group says new Glaxo asthma drug far too expensive – Pharmacy Today, American Pharmacists Association, pharmacist.com

Independent group says new Glaxo asthma drug far too expensive
Pharmacy Today, American Pharmacists Association, pharmacist.com
The nonprofit analyzed the once-monthly injectable drug for severe asthma, finding that it should be priced at $7,800 to $12,000 a year, compared with the current list price of $32,500 a year. While the drug significantly reduces asthma attacks and

View full post on asthma – Google News

FDA advisers recommend approval of asthma drug for adults – Pharmacy Today, American Pharmacists Association, pharmacist.com

FDA advisers recommend approval of asthma drug for adults
Pharmacy Today, American Pharmacists Association, pharmacist.com
An FDA advisory committee has recommended the agency approve Teva Pharmaceutical's experimental drug reslizumab for severe asthma in patients aged 18 years and older. Reslizumab is an antibody drug designed to be given intravenously once every …

View full post on asthma – Google News

Study compares LRTAs with placebo for the treatment of asthma – Pharmacy Today, American Pharmacists Association, pharmacist.com

Study compares LRTAs with placebo for the treatment of asthma
Pharmacy Today, American Pharmacists Association, pharmacist.com
Researchers conducted a systematic review and meta-analysis to compare leukotriene-receptor antagonists (LTRAs) with placebo in patients with mild asthma. The review, funded by NIH, included 50 randomized trials conducted through June 2015.

View full post on asthma – Google News